Pharmaron, I-Mab and Burning Rock Get Investor Validation From MSCI
Three up-and-coming Chinese pharma companies are among those included in latest adjustment for the index compiler’s China All Shares Index Key takeaways: MSCI’s addition of Pharmaron, I-Mab and Burning Rock…
RELATED ARTICLES
-
I-Mab gets new CEO after long search. Sale of the company coming next?
IMAB.US
-
Sinking Burning Rock faces de-listing. But could privatization bid come first?
BNR.US
-
Burning Rock narrows losses with drug research as new driver
BNR.US
- CHINA BULLETIN: China-U.S. Rapprochement Continues with Xi-Biden Call, Yellen Visit
- CHINA BULLETIN: Bank Loan Growth Hits Record Low
- CHINA BULLETIN: China Eases Up on Cross-Border Data Requirements
- CHINA BULLETIN: Bring on the Equipment Upgrades, Says Beijing
Discover hidden China stock gems in our weekly newsletter